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Abstract
Wide variation exists in the extent (number and diameter) of native pre-existing collaterals in 
tissues of different strains of mice, with supportive indirect evidence recently appearing for 
humans. This variation is a major determinant of the wide variation in severity of tissue injury in 
occlusive vascular disease. Whether such genetic-dependent variation also exists in the heart is 
unknown because no model exists for study of mouse coronary collaterals. Also owing to 
methodological limitations, it is not known if ischemia can induce new coronary collaterals to 
form (“neo-collaterals”) versus remodeling of pre-existing ones. The present study sought to 
develop a model to study coronary collaterals in mice, determine whether neo-collateral formation 
occurs, and investigate the responsible mechanisms. Four strains with known rank-ordered 
differences in collateral extent in brain and skeletal muscle were studied: C57BLKS>C57BL/6>A/
J>BALB/c. Unexpectedly, these and 5 additional strains lacked native coronary collaterals. 
However after ligation, neo-collaterals formed rapidly within 1-to-2 days, reaching their maximum 
extent in ≤ 7 days. Rank-order for neo-collateral formation differed from the above: C57BL/
6>BALB/c>C57BLKS>A/J. Collateral network conductance, infarct volume−1, and contractile 
function followed this same rank-order. Neo-collateral formation and collateral conductance were 
reduced and infarct volume increased in MCP1−/− and CCR2−/− mice. Bone-marrow transplant 
rescued collateral formation in CCR2−/− mice. Involvement of fractalkine→CX3CR1 signaling 
and endothelial cell proliferation were also identified. This study introduces a model for 
investigating the coronary collateral circulation in mice, demonstrates that neocollaterals form 
rapidly after coronary occlusion, and finds that MCP→CCR2-mediated recruitment of myeloid 
cells is required for this process.
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Most tissues have a native collateral circulation composed of infrequent arteriole-to-arteriole 
anastomoses that cross-connect the crowns of adjacent arterial trees [1–6]. The pressure drop 
that occurs across them after a sudden occlusion in the trunk of one of the trees causes blood 
to flow across the collateral network. By providing an alternative route for flow, collaterals 
can significantly lessen ischemic injury depending on their number and diameter, ie, 
“extent”. In animal models of sustained arterial obstruction, collaterals in the brain and 
lower extremities remodel (enlarge) their anatomic lumen diameter by shear stress-induced 
and, depending on the tissue, hypoxia-induced processes that require days-to-weeks for 
completion [1–7]. The ability of remodeling to reduce final infarct volume depends on the 
collateral extent at baseline before obstruction, the volume of ischemic penumbra or border 
zone surrounding the necrotic core, the tolerance of the tissue to ischemia, how rapid 
remodeling occurs, and how much collateral diameters increase. Collateral remodeling in 
heart, where these vessels are difficult to image directly, is believed to underlie the 
progressive increase with time in collateral-dependent flow in animal models of and patients 
with acute myocardial infarction (MI), coronary artery disease (CAD) and acute coronary 
syndrome [1–6].
Indirect measures of collateral-dependent blood flow suggest that native collateral extent in 
heart, brain and lower extremities varies greatly among “healthy” humans, ie, in the absence 
of CAD [4] or peripheral artery disease [8] or when assessed in the hyper-acute phase of 
ischemic stroke [9,10], ie, conditions where remodeling—which can also vary among 
individuals [1–7,11–15]—has not yet taken place. This variation at baseline has been 
suggested to be a major determinant of the wide variation in the severity of tissue injury 
when arterial obstruction develops [4,5,7,9–15]. Consistent with these studies, among 
patients in which thrombolytic treatment failed to elicit reperfusion during the acute phase of 
MI, those with “good/high” collateralization had 35% smaller infarct volumes [16]. 
Similarly, in patients with CAD, those with good collaterals had a 36% lower mortality risk 
than those with poor collaterals [4]. The cause of this variation in collateral circulation is 
unknown. However, recent studies in mice have found that differences in genetic 
background may be a major factor [5,7,12–15]. Collateral extent in brain varied 46-fold 
among 21 strains of mice [14], with large variation also present in skeletal muscle and 
intestine examined in several of the same strains [11–13]. The differences correlated with 
wide differences in tissue injury in models of acute and chronic arterial obstruction in brain 
(eg, 30-fold variation in infarct volume [7]) and lower extremities [12,13]. Approximately 
85 percent of the variation in both collateral extent and tissue injury was recently linked to a 
polymorphic genetic locus (Dce1), which when introgressed from a strain with abundant 
collaterals into one with poor collaterals, completely rescued the collateral deficit and 
functional outcome attributable to the locus [15]. This locus is thus a critical link in the 
pathway that directs collaterogenesis, ie, formation of native collaterals. In mouse brain 
[17,18] and human heart [19] collaterogenesis occurs during development after the general 
arterial-venous circulation has formed, and in mouse determines collateral extent in the 
adult.
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Whether such genetic variation in native collaterals also exists in heart to explain the above 
findings in humans [4,16] is unknown because of absence of methods to study the coronary 
collateral circulation in mice—the mammalian species most amenable to genetic 
manipulation. This presumably is because of the complex three-dimensional arrangement of 
the coronary circulation and difficulty in distinguishing collaterals from other vessels 
(problems not confined to mice), phasic contraction of the heart which in mouse exceeds 
550 beats per minute, small size of the mouse heart, and difficulty in studying its coronary 
circulation. It is also not known if occlusive disease can induce new coronary collaterals to 
form. It has generally been assumed [1] (but not without exception [3]) that only remodeling 
of native collaterals occurs after arterial stenosis or occlusion. However, this assumption 
remains uncertain because of limitations in resolution of previous angiographic methods: 
native collaterals can be as small as the smallest arterioles in a tissue (~6–8 microns 
diameter), are thousands-fold less abundant than nearby arterioles (eg, in skeletal muscle 
[11]), and can only be anatomically differentiated from the latter by identifying their 
anastomotic connections. Once collaterals have remodeled after arterial occlusion, their 
many-fold larger diameter and increased tortuosity makes them somewhat easier to identify. 
However, the number then detected would reflect native collaterals that have remodeled and
—if in fact it occurs—de novo formation of additional ones (“neo-collaterals”5). And neither 
native collaterals nor neo-collaterals could be distinguished from each other based on 
diameter, since the amount of remodeling of native collaterals would depend on their 
baseline diameter [7,13] (the primary determinant of shear stress) and the vigor of the 
pathways controlling the remodeling process [1–6], while the final diameter of any neo-
collaterals that formed would reflect the process of de novo collateral formation.
To address the above questions, we first optimized methods to study the coronary collateral 
circulation in mice, namely high resolution three-dimensional angiography, measurement of 
conductance of the collateral network, and histology on single identified collaterals. An 
unexpected finding followed: mice lack a native collateral circulation in heart even though 
they have collaterals in their other tissues. This surprising outcome, however, allowed us to 
unambiguously ask whether new collaterals form after arterial obstruction. Patent neo-
collaterals indeed appeared rapidly within 1-to-2 days after acute MI and achieved their 
maximal number and diameter within 7 days. Neo-collateral formation varied with genetic 
background. Strains with greater formation had greater collateral conductance, smaller final 
infarct volumes, and better recovery of contractile function. However, the strain-specific 
pattern differed from that seen for differences in extent of the native collateral circulation in 
brain and other tissues of the same strains [7,12,13], indicating that different mechanisms 
direct collaterogenesis in the embryo and neo-collateral formation in the ischemic adult 
heart. In addition, we found that bone-marrow-derived myeloid cells and MCP1→CCR2, 
and to a lesser degree fractalkine→ CX3CR1 signaling, were required. This study provides a 
model to study new collateral formation after acute myocardial infarction that may identify 
novel targets for treatment of ischemic disease.
2. Methods
See the online Data Supplement for additional details.
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Mice, guinea pigs and rats were male and 3–5 months-old, except in the following 
experiments: inbred strains of mice on day-1 after ligation; measurement of retrograde fill 
time and infarct volume; bone marrow transplants; CCR2 and CX3CR1 marker mice. These 
used ~equal numbers of male and female mice.
2.2. Coronary ligation, micro-angiography, morphometry, collateral conductance
The left anterior descending coronary artery was ligated 3mm below the left atrial margin 
(LADX) to produce a small infarction of 10–20% of left ventricle-plus-septum (LVS) wall 
volume, thus minimizing stimuli for compensatory hypertrophy and vascular growth that 
otherwise occurs in the normal (remote) myocardium following a large MI [3]. 
Approximately 99% survival occurred. Proximal ligation to produce a larger infarction 
(~45% of LV volume) was also examined in a separate group of B6 mice, wherein ~50% 
survived without evidence of heart failure as reported previously [20]. Immediately or 
specified days after LADX, mice received one or more of the following after administration 
of heparin, maximal dilation with papavarine and nitroprusside, and fixation with 
paraformaldehyde to prevent any subsequent constriction (“hep-dil-fix”): 1) arterial 
angiography following infusion of MicrofilR and optical clearing to determine the number 
and lumen diameter of neo-collaterals within the border zone connecting distal branches of 
the LAD to adjacent circumflex, right coronary and septal arterial trees; 2) measurement of 
either the time−1 required to backfill the LAD tree to the point of ligation with Microfil or 
microsphere trapping (both administered at a constant inflow pressure) to determine the 
relative “conductance” or blood flow, respectively, of the nascent collateral network; 3) 
perfusion of Evans blue-in-phosphate buffered saline (PBS) to determine the territory of the 
LAD tree below the ligation.
2.3. Infarct volume, dp/dt analysis, histology, cell proliferation, apoptosis, bone marrow
transplantation Infarct volume was measured using 2,3,5-triphenytetrazolium chloride 
staining (TTC) and cardiac function using dp/dt analysis. Histology was performed for neo-
collaterals that were identified after hep-dil-fix, filling and clearing by: 1) their cross-
connecting the LAD and adjacent arterial trees, and 2) retension of Microfil in their lumen 
following dissection of the tissue micro-block containing the collateral and sectioning at 8-
microns. To determine cell proliferation, EdU (5-ethynyl-2′-deoxyuridine) was injected on 
day-2 and day-4 after LADX, followed by dissection of neo-collateral-containing tissue 
blocks on day-7. Bone marrow transplant was performed to generate EGFP;B6-transgenic 
mice and 4 reciprocol CCR2−/−;C57BL/6 (B6) chimeras.
2.4. Statistical analysis
Data (mean±SE) underwent t-tests, ANOVA, Bonferroni tests, or linear regression (p<0.05 
= significant). Where possible, data were collected by investigator blinded to treatment 
group.
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3.1. Mice lack native coronary collaterals
We used an angiographic casting method previously used to quantify native collaterals in 
other tissues of mouse [7,11–15]. Surprisingly, no coronary collaterals were present in B6 
mice (Figure 1) or 7 other inbred strains [C57BLKS (BLKS), A/J, BALB/cBy (BALB/c), 
C3H-He, CBA, DBA/2, SJL (n≥5 each)], nor in CD1 outbred mice (n=3). This was 
unexpected since these strains have native collaterals in brain and other tissues where they 
are: most abundant in BLKS, abundant in B6, CBA, DBA/2, SJL, CD1, C3H-He, less 
abundant in A/J, and least abundant in BALB/c [7,13,15]. Absence of coronary collaterals 
was irrespective of sex.
To confirm this unexpected finding that, unlike other mammals extending from rat to human 
[4,21–23], mice lack native coronary collaterals, we used 5 additional methods to be certain 
that coronary collaterals with very small diameters had not escaped detection: 1) casting 
with low-viscosity Microfil or with high pressure to insure filling of the capillary bed 
(Figure 1C, Online Figures 1,2); 2) casting after minimizing resistance downstream of any 
extant native collaterals by transection of the LAD just distal to its point of ligation (Figure 
1D,E); 3) perfusion with Evans blue-PBS (viscosity same as water; Online Figures/Videos 
3–5); 4) endothelial staining with either intravascular IB4-lectin-Alexa-568, or 5) using 
endothelial ephrin-B2LacZ/+ transgenic mice on both B6 and BALB/c backgrounds (data not 
shown). No collaterals were detected with any of these additional methods. Only capillaries 
(Figure 2) were present within the watershed zone between adjacent arterial trees. They 
averaged 4.7 microns in diameter, thus our methods can readily detect the smallest vessels in 
the mouse heart.
We wondered if the absence of coronary collaterals in the mouse species is due to the steep 
increase in heart rate that occurs during the first several weeks after birth (350 on postnatal 
day- 0–1 rising to 550–650 beats per minute in the young adult) [24,25]. We reasoned that 
the phasic blood flow and pressures unique to the coronary circulation might create—in 
mouse with its short diastolic intervals—hemodynamic conditions in nascent collaterals 
favoring their regression. That is, it is known that chronic level of shear stress influences 
growth of the native coronary collateral circulation: conductance of the coronary network 
correlates directly with the time in diastole, which is when the majority of coronary 
perfusion occurs [3,29,30]; after birth the proportion of time in diastole declines since heart 
rate rapidly increases to 550–600 bpm as mice grow to sexual maturity [24]. Despite this 
reasoning, collaterals were also absent in in VECADGFP/+ pups on postnatal day-1 and-2 
(data not shown) and in 3 week-old B6 mice (Online Figure 6), when formation of native 
collaterals in other tissues has achieved the number and diameter present in the adult 
[17,18].
To further validate our casting method, we confirmed as a positive control its ability to 
detect collaterals in guinea pigs and rats. These species have been shown, either by 
measuring infarct volume or collateral-dependent flow (microspheres) shortly after ligation 
[21,22], or using angiography in rat [23], to have abundant and sparse native coronary 
collaterals, respectively. Guinea pigs do not sustain infarctions after proximal LADX, 
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leading to the assumption that they have abundant collaterals [21,22]. The data in Online 
Figure 7 show this assumption is correct. Collectively, the above findings using 5 different 
methods plus positive “controls” demonstrate that, unlike other mammalian species 
examined by ourselves and others [21–23], mice lack native collaterals in heart despite 
having them in their other tissues.
3.2. De novo formation of collaterals occurs rapidly after coronary occlusion
It has long been assumed that only remodeling of native collaterals occurs after arterial 
occlusion. Our findings that mice lack native coronary collaterals provided an opportunity to 
address this question directly, since unlike in previous studies, no pre-existing collaterals 
exist to complicate interpretation of results vis-à-vis collateral remodeling.
An exciting result occurred after distal LADX. New collaterals (“neo-collaterals”5) began 
forming within 1-to-2 days and reached their maximum number and diameter within 4-to-7 
days, ie, ~10 collaterals cross-connecting to distal branches of the LAD with an average 
lumen diameter of ~18 µm; no significant change in number or diameter was observed after 
7 days (Figure 2, Online Figure 8). Placing the suture knot adjacent to the LAD (sham 
LADX) had no effect. Ligation 2mm proximal to the standard ligation used above and 
elsewhere in this study, which caused a larger infarction (~45% of left ventricular volume) 
where once again no native collaterals were detected, caused twice as many neo-collaterals 
to form by day-7 (Online Figure 9).
3.3. Variation in neo-collateral formation, collateral network resistance, and severity of 
infarct volume accompany differences in genetic background
Previous studies in mice found that native collateral number and diameter (collateral extent) 
in brain, skeletal muscle and intestine vary widely with genetic background [7,13 –15]. This 
variation closely correlated with a similarly wide variation in the same strains in severity of 
tissue injury following arterial occlusion. Linkage, SNP-association among 21 strains, and 
congenic analyses showed that a single locus, Dce1, is responsible for 85% of this variation 
[14,15]. Strain-specific differences in native extent in the adult are specified during 
formation of the collateral circulation (collaterogenesis), which occurs during the perinatal 
period [17,18]. To determine if ischemic neo-collateral formation in adult heart also varies 
with genetic background in a manner suggesting linkage to Dce1, we performed LADX on 4 
strains with the largest rank-order difference in native collateral extent (in brain and other 
tissues) among 21 strains [14]: BLKS > B6 > A/J > BALB/c. If variants of the Dce1 allele 
also mediate variation in neo-collateral formation in ischemic heart, the latter should follow 
this same rank-order. However, BALB/c mice formed neo-collaterals with a similar number, 
diameter and 14-day time-course as shown in Figure 2 for B6 mice, although number was 
lower on day-14 in BALB/c (p<0.05, data not shown); moreover, BLKS and A/J strains 
formed fewer collaterals of smaller diameter (Figure 3A,B). Thus the rank-order for neo-
collateral formation in heart does not follow the rank-order for native collaterogenesis in 
other tissues of these strains, suggesting different underlying mechanisms.
To examine the functional significance of neo-collateral formation, we developed a method 
to estimate relative resistance/conductance of the collateral network supplying the territory 
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below the ligation, based on transit time for retrograde filling of low-viscosity MicrofilR 
back to the point of ligation of the LAD (“retrograde fill-time”; Figure 3C, Online Figure/
Video 10). As expected from the data in Figure 2E, no filling occurred at day-0 and day-1 
after ligation in B6 mice (Figure 3C’s inset bar graph); fill-time then declined 
~exponentially. Also as expected from Figure 3A,B, fill-time one week after LADX, when 
maximal neo-collateral formation was achieved, varied inversely with strain-dependent 
variation in formation (Figure 3C). Unlike the above data for neo-collateral formation which 
were for male mice, fill-time was determined using both male and female BALB/c and B6 
mice (n=6–7 of each sex). No sex-specific difference was seen (p=0.60). We also measured 
infarct volume 1 week after LADX in both sexes. As predicted from the relative resistances 
in Figure 3C, the rank-order for infarct volume followed the rank-order for retrograde fill-
time (Figure 3D), resulting in a close correlation (Figure 3E) that did not differ with sex. 
Because we used a small-infarction model to avoid heart failure and the accompanying 
myocardial cell disturbances, we were unsuccessful in detecting significant deficiency in 
pump function on day-7 using echocardiography (Vivo 2100, Visualsonics Inc). However, 
contractile function as assessed by dP/dt analysis demonstrated that A/J mice exhibited 
greater deficits than B6 (Figure 4A). These findings are not due to differences in territory of 
the LAD tree below the ligation (Online Figure 11).
Baseline data: Body weight for 3–5 months-old male B6, BALB/c, BLKS and A/J strains 
did not differ, and none of the above data correlated with body weight, arterial pressure or 
heart rate for the strains (see Online Methods for data). Although cardiac function assessed 
in these strains at baseline by the same lab has not been reported, some data are available. 
B6 and BALB/c body:heart weight ratio did not differ [20,26], whereas dP/dt+ was greater 
in B6 but dP/dt−, LVEDP, LVESP and tau did not differ [26]. In isolated hearts, these 
metrics did not differ between B6 and BALB/c (and 6 other strains not including BLKS and 
A/J) at baseline, after 20 minutes of ischemia, and after 60 minutes of reperfusion 
(differences were seen, however, using in vivo, albeit open-chest, PV loop analysis) [27]. 
Cardiac function assessed by echocardiography and radiotelemetry did not differ between 
B6 and BALB/c [20,28].
The above results demonstrate that neo-collateral formation varies with genetic background, 
is independent of sex, and results in closely correlated variation in ischemic tissue damage 
and deficits in developed pressures; these data do not associate with differences in baseline 
parameters.
3.4. Nascent neo-collaterals and surrounding bone marrow-derived cells types
To begin to understand the mechanisms underlying neo-collateral formation in ischemic 
heart, we performed histology on single neo-collaterals identified after filling, optical 
clearing, microdissection of the tissue block surrounding the collateral, and sectioning—
wherein microfil was retained in the collateral lumen of the tissue sections as an additional 
confirmation (see Online Figure 12 for methods). Seven days after LADX, monocytic and 
myocardial cells were evident in the vicinity of the neo-collaterals in the border zone/
shoulder region (Figure 4B,C). Neo-collaterals were invested with αSMA+ cells having the 
morphology of smooth muscle cells (Figure 4E). Interestingly, cardiomyocytes were 
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commonly seen adjacent to venules and collaterals in the infarcted region next to the border 
zone (Figure 4B,C). This has been reported previously for venules [29,30].
We transplanted bone marrow from B6;GFP constitutive ubiquitously expressing transgenic 
mice into wildtype B6 mice. Seven days after LADX, lectin+/GFP+ bone-marrow derived 
cells (BMC) were present in the border zone and vicinity of nascent collaterals (Online 
Figure 13; see also Figure 7A–D). Less abundant lectin−/GFP+ (Online Figure 13, white 
stars) and lectin+/GFP− cells (red stars) were also present. It is possible that the former are 
bone marrow-derived CX3CR1+ macrophages (confirmed below). Similar results were 
obtained using direct fluorescence instead of anti-GFP immunohistochemistry (Online 
Figure 13). CD45+/lectin+ and CD45+/lectin− cells were also present (Online Figure 13E,F). 
In contrast, both cell types were less abundant in MCP1−/− and CCR2−/− mice (Online 
Figure 13G,H). Perivascular CD34+/lectin− cells were also evident (Online Figure 14). No 
GFP+ BMCs or CD45+ or CD34+ cells were observed in the neo-collateral wall, thus no 
evidence for engraftment of hematopoietic cells (Figure 5, Online Figures 13,14). 
Retrograde fill-time was not altered in mice genetically deficient for lymphoid cells (38±5 
versus 37±6 seconds; n=6 each of nude mice and their wildtype (het) controls (Nu/J, 
#002019, outbred population, Jackson Labs)). This indicates that T-cells are not required for 
neo-collateral formation.
3.5. Neo-collateral formation is dependent on MCP1→CCR2 signaling
Given the above finding of several myeloid cell types adjacent to nascent collaterals, we 
tested the hypothesis that monocyte chemoattractant protein-1 (MCP1) is required for 
ischemic collaterogenesis. MCP1 is released from cardiomyocytes, ECs, SMCs, and a 
variety of hematopoietic and other cell types in ischemic, injured, inflamed and tumorigenic 
tissues and binds CCR2 receptors that are present on monocytes, CD4 T-cells, ECs, 
endothelial progenitor cells (EPCs) and mesenchymal stem/stromal cells (MSCs) [31–33]. 
MCP1→CCR2 signaling is a major effector of homing of BMCs, adhesion to endothelium, 
transmigration, and secretion of additional MCP1 and other chemokines and cytokines. Neo-
collateral formation was reduced and infarct volume increased in MCP1−/− and CCR2−/− B6 
mice (Figure 5). The smaller effect of deletion of MCP1 compared to CCR2 on neo-
collateral formation and absence of effect on retrograde fill-time may reflect contribution 
and/or compensation by other MCP family members that also bind CCR2 [31–34]. 
Microsphere trapping was used to confirm the ability of the fill-time method (Figure 3) to 
estimate collateral-dependent flow, and to confirm its reduction in CCR2−/− mice as 
predicted by the above results (Online Figures 15,16). Given the possible presence of 
CX3CR1+ M2 macrophages in the vicinity of developing neo-collaterals (Figure 5A–D, 
Online Figure 13, see also below), we examined CX3CR1−/− B6 mice. Neo-collateral 
diameter but not number was reduced (Figure 5).
These results indicate that MCP→CCR2 and to a lesser extent fractalkine→CX3CR1+ 
signaling pathways are required for neo-collateral formation. Consistent with this, CD45+/
lectin+ and CD45+/lectin− cells were less abundant in the vicinity of the smaller (and fewer) 
neo-collaterals that formed in MCP1−/− and CCR2−/− mice (Online Figure 13G,H). 
Likewise, 5 days after ligation of CCR2RFP/+ and CX3CR1GFP/+ reporter mice (B6 
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background, Jackson Labs), CCR2- and CX3CR1-expressing cells were strongly recruited to 
the border zone and found in close proximity to neo-collaterals (Figure 6). Both cells types 
were also present in much fewer numbers 1 day after LADX (data not shown). Potential 
EPCs/hematopoietic precursors were also evident as Flk1+ cells not expressing CCR2RFP/+ 
or CX3CR1GFP/+. αSMA+ staining identified abundant myofibroblast-like cells in the 
interstitium and presence of mural cells displaying the morphology of pericytes and SMCs 
(Figure 6B–E, Figure 5E).
To confirm the above conclusion that CCR2+ cells have a major role in ischemic 
collaterogenesis, to test whether they are recruited from bone marrow versus elsewhere, and 
to address the fact that CCR2−/− mice have reduced monocyte egress [34], we did bone 
marrow transplants of B6 and CCR2−/−;B6 mice (Figure 7). Transplant of wildtype BMCs 
into CCR2−/− mice rescued neo-collateral formation by 73% (Figure 7E). In addition, 
transplant of CCR2−/− BMCs to wildtype mice inhibited neo-collateral formation by the 
same amount as in CCR2−/− mice. Autologous reconstitution of wildtype and knockout mice 
BMCs showed no effect of the transplant procedure per se (Figure 7E). Of note, the small 
infarct model we employed produced endocardial infarctions in the territory at risk (Figure 
7A,C), with diffusion of oxygen from the ventricular lumen and epicardial arteries 
presumably protecting the subendocardium and epicardium, respectively. Consistent with 
this, we found neo-collaterals only formed within the endocardium where hypoxia and 
pressure gradients across the capillary plexus in the watersheds would be the greatest 
(discussed below).
Compared to B6 mice, neo-collaterals of A/J and CCR2−/− showed reduced EC proliferation 
at day-7 (Online Figure 18), consistent with the fewer collaterals of smaller diameter that 
these strains form. Collateral endothelial cells that had undergone proliferation over the 7 
days of pulse-labeling were widely dispersed. This pattern is inconsistent with the notion 
that neo-collateral formation begins with formation of new capillaries cross-connecting 
adjacent trees to the LAD (see Discussion). No apoptosis was observed within the walls of 
neo-collaterals, although occasional apoptotic cells were seen in the vicinity (Online Figure 
19).
4. Discussion
A surprising finding in this study is that mouse heart lacks native coronary collaterals, given 
that the strains we examined have collaterals in their brain, skeletal muscle, intestine and 
skin (ear) [7,11–15,35]. Absence of coronary collaterals, as assessed immediately after 
ligation, was not due to failure to detect them. We used the same filling and optical clearing 
methods that we have used to determine collateral number and diameter in other tissues, 
including in strains of mice with collaterals that are both few in number and small in 
diameter (ie, BALB/c and A/J) [7,13–15]. Also, as positive controls we confirmed reports 
suggesting that rat has sparse [21,23] and guinea pig abundant [21,22] collaterals. We 
employed five additional methods that filled or stained capillaries, ie, the smallest vessels in 
heart that averaged 4.7 microns in diameter: use of Microfil at lower-viscosities or higher 
pressures than used above; reducing downstream resistance by transection of the LAD 
below the ligation before infusion of Microfil; endothelial staining with LacZ in ephrin-
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B2LacZ/+ mice or with lectin (staining was followed by optical clearing); perfusion with 
saline containing Evans blue dye. None of these methods detected native collaterals. All of 
the above methods were conducted after maximal dilation and fixation at this maximum. 
This absence was not a function of genetic background. No collaterals were found in nine 
strains that span the range, among 21 inbred and wild-derived strains, from most-to-least 
number of collaterals in their non-heart tissues (eg, ~30 in the neocortex of BLKS versus 0-
to-1 in BALB/c) [7,13–15,17].
The apparent absence of coronary collaterals in mouse is unique among mammals studied. 
Injection of microspheres after acute ligation of the circumflex artery identified a native 
coronary collateral circulation in all eight non-murine mammalian species examined [21]. 
However, collateral flow as indicated by percent of microspheres trapped in the ischemic 
versus non-ischemic (remote) zone varied widely. Collateral flow was 100% in guinea pig, 
16% in dog, 12% in cat, 6% in rat, and “low” in 4 species, ie, 2% in ferret, baboon and 
rabbit, and 1% in pig. The accuracy of these values may have been affected by not 
administering heparin and a smooth muscle dilator followed by a fixative (as used herein), 
use of 15 micron microspheres whose presence in the ischemic zone will vary with collateral 
diameter, and possible presence within the dissected ischemic zone of microsphere-
containing distal-most arterioles from the surrounding non-ischemic trees. However, infarct 
volumes measured at 1.5, 3 and 6 hours after acute ligation for several of the species are 
qualitatively consistent with these differences (guinea pig = no infarction, cat > dog > rabbit 
= pig) [22]. Nevertheless, it is noteworthy that only a single inbred strain of each species 
was examined (ie, Dunkin-Hartley guinea pig, greyhound dog, Wistar rat, New Zealand 
White rabbit) [21] or likely-to-be closely interbred/related individuals (ie, ferret, baboon) or 
breed-stock (pig, breed not given) [21.22]. Given the wide variation in native collateral 
extent among different mouse strains [7,13–15] and collateral-dependent flow among 
“outbred” humans [4,8–10], the often-stated conclusion that these findings [21] are due to 
species-specific variation in native collaterals requires confirmation using either wild or 
genetically diverse individuals from each species. In fact, while references cited therein [21] 
are consistent for guinea pig (however some reports found mild ischemia after ligation, plus 
there are few commercial strains available), other references therein report that collateral 
flow ranges from 10–30% in dog, is greater in cat than dog, is less than 0.01% in rat, ranges 
from low-to-15% in baboon, and that there is disagreement in rabbit and pig (breeds were 
not given). Elsewhere, Dalland landrace pigs had abundant native collaterals on bismuth 
filling (but 15 micron microspheres yielded a collateral flow of 0.06%—a disagreement that 
the authors suggested could reflect edema-induced vascular compression) [36]. In contrast, a 
recently developed high-resolution three-dimensional imaging technique detected few native 
coronary collaterals in Yorkshire pigs [37]. Notwithstanding methodological limitations, the 
above reports are consistent with the concept that native collateral extent varies among 
species and among different strains and breed-stock within a species. However, our finding 
that mice lack native collaterals apparently regardless of strain (we did not study wild mice 
and ~500 other inbred strains) is unique among species examined.
We can only speculate on why the above-mentioned larger mammals have native coronary 
collaterals while mouse does not. One possibility, predicated on a second speculation [5], is 
that collaterals in healthy tissues, by contributing flow from an adjacent tree to a locally 
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metabolically dilated region of a given tree, help to optimize or fine-tune regional oxygen 
delivery to meet regional oxygen demand, particularly in tissues that exhibit large changes 
in metabolic rate and high oxygen demand (eg, striated muscle, brain). This optimization 
would include within the watershed region/zone between adjacent arterial trees, where 
terminal arterioles can be seen branching from collaterals [7]. Given the small size of the 
mouse heart, its watersheds may be sufficiently narrow (eg, Figures 1,6) that diffusion of 
oxygen is adequate and collaterals are not needed to “scaffold” terminal arterioles. While 
this may explain why mouse heart lacks native collaterals, it does not explain why there is a 
strain difference in neo-collateral formation for the same size infarction and area at risk. We 
presume the latter is due to gene variants among the strains in the cells and signaling 
pathway that drive neo-collateral formation (discussed below). The hypothesis that native 
collaterals may, in the absence of obstruction, serve to optimize oxygen supply-to-demand, 
and thus that hypoxia-related adaptive mechanisms may exist to increase collateral extent is 
supported by the finding that chronic anemia in dogs, pigs and humans is accompanied by 
increased collateral conductance [38.39 and references therein]. However, anemia caused 
biventricular hypertrophy and growth of the overall coronary circulation. Thus, the extent to 
which the effect of anemia reflects remodeling of pre-existing collaterals, caused by a 
pressure difference across them [1,6,22] as well as local hypoxia [2,3], and/or neo-collateral 
formation remains to be determined.
The most important finding of our study is that patent collaterals formed after coronary 
ligation. A long-standing controversy has existed regarding whether collateral-dependent 
perfusion, which begins to increase in hindlimb by three days after arterial obstruction and 
continues to increase for several weeks afterwards [1–6,11–13,15], is due only to outward 
remodeling of native collaterals (arteriogenesis) or also depends on formation of additional 
collaterals (neo-collaterals). This uncertainty extends in part from the difficulty in 
distinguishing pre-existing collaterals from much more abundant nearby arterioles. It has 
generally been assumed that only remodeling of native collaterals occurs. Our finding that 
mice lack pre-existing coronary collaterals provided an opportunity to address this 
controversy since no native collaterals exist to complicate interpretation of results vis-à-vis 
collateral remodeling. This is the first study to show that new collaterals form 
physiologically in the ischemic heart. That this can be induced to occur surgically comes 
from the observation that trans-positioning a length of the intact mammary artery and 
attendant perivascular tissue and vasa vasorum onto the ischemic region of the myocardium 
of patients with CAD resulted in more than 50% of the implants establishing connectivity to 
the arterial circulation within the territory at risk [40]. And an anatomically analogous 
surgical procedure is used to treat certain types of cerebral arterial occlusions [41]. Neo-
collateral formation following arterial occlusion has been reported in brain [7] and skeletal 
muscle [42] of strains of adult mice that have low numbers of native collaterals. Although 
the mechanism was not examined, neo-collateral formation was not seen in strains with 
abundant collaterals, leading us to hypothesize that this was because the ischemic region in 
these strains was well-removed from the watersheds where collaterals form, ie, that de-novo 
collateral formation requires ischemia (discussed below). An important future question is 
whether neo-collateral formation occurs in species, including human, endowed with native 
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coronary collaterals. The above studies in mouse brain and skeletal muscle support the 
possibility.
Collaterals and retrograde perfusion of the—interestingly, still-intact and patent LAD tree—
appeared rapidly by day-2. This is similar to brain, where patent neo-collaterals were not 
seen at day-1.5 after arterial ligation but were present by day-3 [7], and in skeletal muscle 
where they were not evident at day-2 but present by day-4 [42]. Collateral formation is 
faster than the onset of growth of arterioles in the surviving (remote) myocardium, which 
was seen 7 days after a large MI in association with increased wall stress and compensatory 
hypertrophy [3]. Nevertheless, coronary neo-collateral formation is too slow to prevent 
development of a necrotic core, which occurs within ~30 minutes after ligation [3,4,43,44]. 
Importantly however, blood-borne immune cells delivered to the core via collaterals, as 
opposed to the otherwise much slower route via migration through the vascular wall and 
interstitium, would be expected to speed removal of cell debre, reduce the amount and 
duration of inflammation, and aid delivery of circulating mesenchymal fibroblast precursors. 
This would favor more efficient scar formation, oppose adverse ventricular remodeling, and 
improve recovery of pump function. Interestingly, scar volume related inversely to the 
number of visible collaterals in patients [44]. Of equal or more importance, neo-collateral 
formation would also be expected to reduce the volume and severity of ischemia and 
accompanying injury in hibernating myocardial cells in the outermost territory of the 
occluded tree and its adjacent watersheds/border zones. This would promote salvage of a 
portion of the area at risk, leading to a smaller final infarct volume. Neo-collateral formation 
would also speed delivery of cardiac and vascular progenitor cells to this area, which 
evidence suggests promote myocardial repair, neo-vascularization, favorable chamber 
remodeling, and recovery of function [1–4,45–55]. Although additional studies will be 
required to examine these hypotheses, our findings that infarct volume and heart function 
closely associate with the extent of neo-collateral formation in mice with differences in 
genetic background and mice genetically deficient in MCP1 or CCR2 are consistent with a 
beneficial effect of collateral formation even if it does not begin until 1-to-2 days after acute 
myocardial infarction. Interestingly, Zhang et al found in pigs that intracoronary injection of 
labeled CD34+ BMCs upstream of LAD ligation done two weeks earlier increased Rentrop-
score, pump function, vessel density, SDF-1 and bFGF, and CD34+ cells in the vicinity of 
vessels in the peri-infarct region when examined several weeks later [56]. Furthermore, 
these effects were more pronounced in pigs that had greater Rentrop scores at the time of 
injection, leading the authors to suggest that collaterals serve as a conduit to aid homing of 
BMCs to ischemic myocardium leading to better recovery of function.
Mice genetically deficient in T-cells evidenced no deficit in neo-collateral formation, thus 
myeloid but not lymphoid cells are required. Formation required MCP1 and CCR2 receptor 
signaling, since it was inhibited by ~50% in MCP1−/− and CCR2−/− mice. This conclusion 
was confirmed with deficiency and rescue experiments using CCR2 bone marrow chimeras 
and histological identification of bone-marrow derived CCR2+ cells in the vicinity of 
nascent neo-collaterals using genetic reporter mice. Hypoxia/ischemia, increased fluid shear 
stress, and myocardial and SMC cell stretch, which are all present in the border zone, induce 
expression of VEGF from cardiomyocytes and ECs which in turn express MCP1 [1–
4,6,22,54,55]. MCP1 increases within hours after acute MI in infarct and border zones and is 
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sustained through day-28 in mouse [57,58]. In humans, serum levels are not elevated early-
on but rise from 12–24 weeks [58]. MCP1stimulates release, homing to heart, EC adhesion, 
and diapedesis of CCR2+ BMCs and monocytes which are skewed by CCR2 activation to 
the M1 macrophage (CCR2+, CX3CR1low, lectin−, CD45+) —IL6/1β, TNFα-expressing 
inflammatory phenotype that itself also releases MCP1 [59,60]. Monocytes, T-cells, EPCs, 
SMCs and mesenchymal stem/stromal cells (MSCs) are CCR2+ [31–33]. Consistent with a 
role for M1 monocytes and progenitor cells in neo-collateral formation, we detected fewer 
lectin−/CD45+, lectin−/CD34+ cells around nascent neo-collaterals in MCP1−/− and CCR2−/− 
mice that both formed fewer collaterals in association with lower collateral network 
conductance and greater infarct volumes. We also found less EC proliferation in neo-
collaterals of CCR2−/− and A/J mice, in agreement with their deficit in neo-collateral 
number, diameter and network conductance. Interestingly, MCP1 is protective in post-MI 
ischemia-reperfusion, and MCP1→CCR2 activity decreases adverse ventricular remodeling 
[49,61–63]. However, MCP1 may also be harmful, a paradox that may relate to fibrosis and 
remodeling [61,63]. Recently, Arslan and coworkers [48] found that patients with CAD and 
abundant coronary collaterals on Rentrop had increased numbers of peripheral monocytes 
and the CD14++/CD16− subset (also known as CCR2+/CX3CR1low M1 classical monocyte/
macrophage). Morimoto et al [49] demonstrated that mice with cardiac overexpression of 
MCP1 had reduced infarct volume and adverse chamber remodeling two weeks after 
coronary ligation. However, whether these results reflect neo-collateral formation and/or 
remodeling cannot be determined, since it is well-known that MCP1→CCR2 signaling also 
contributes to collateral remodeling in animals [1,3,6,22,55] and is associated with increased 
Rentrop grade after MI in patients [46,47,54]. Of note, we found that neo-collateral 
formation was inhibited less in MCP1−/− than CCR2−/− mice. MCP1–4, CCL12 and CCL16 
ligate CCR2 [31], and MCP3 can mediate homing of MSCs to the ischemic heart [64] and 
induce coronary smooth muscle cell proliferation in vitro [65]. Thus more than one CCR2 
ligand may be involved in neo-collateral formation or compensate in the absence of MCP1.
Macrophages are polarized in vitro toward M2 phenotypes by IL-4 and IL-13 (M2a), 
immune complex-FcγR/TLR (M2b), and IL-10,TGF-β and glucocorticoids (M2c) [59,60]. 
Ischemic/inflammatory myocardium and ECs and SMCs release fractalkine (CX3CL1) to 
recruit CCR2lo-CX3CR1hi M2 monocytes to the ischemic area via CX3CR1 [6]. 
Macrophage and SMC cross-talk via fractalkine→CX3CR1 signaling enhances expression 
of TNFα, IL-1β, IL-6, CX3CR1 and matrix metalloproteinases [66]. Fractalkine has anti-
apoptotic and proliferative effects on SMCs [67–70]. Secretion of these proteins and their 
cross-talk promote differentiation of αSMC-actin+ mural cells. Fractalkine, the only member 
of the CX3C chemokine family, is membrane-bound through the chemokine domain which 
attaches via a mucin-like stalk to the cell surface. It is expressed on neurons, epithelial cells, 
macrophages, and at low levels on ECs, SMCs and cardiomyocytes, while CX3CR1 is 
expressed by monocytes, natural killer cells, T-cells and SMCs [67–70]. Its expression is 
increased in heart by infarction, heart failure and inflammation [67–70]. In the present study, 
involvement of fractalkine→CX3CR1 signaling in neo-collateral formation was indicated by 
its partial inhibition in CX3CR1−/− mice and by histological evidence using genetic reporter 
mice for CX3CR1+ cells in the vicinity of nascent neo-collaterals. Other cell types and 
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signaling pathways are likely involved in the complex process of neo-collateral formation 
[1–4,6,32,33,45,54,55,58,71–78].
Figure 7F presents a model for neo-collateral formation. The capillary plexus within 
watershed zones is interconnected and receives blood flow from the surrounding arterial 
trees that normally returns via the contiguous venous trees down the path of least resistance 
[3,79]. We confirmed these findings in mice (Online Figures 3–5). We propose that arterial 
obstruction causes, within the watersheds, ischemia and increased fluid shear stress toward 
the territory at risk, especially in the largest-diameter capillaries. The latter are relatively few 
in number in capillary plexi in adult heart [3]. Induced expression of MCP1, fractalkine and 
other factors activate CCR2, CX3CR1 and other proteins, leading to recruitment of myeloid 
and vascular progenitors and other cell types from bone marrow and possibly intra- and 
other extra-cardiac tissue sites. Factors from heart and vascular cells and extracellular matrix 
are also released locally. The resulting milieu of growth and remodeling factors includes 
ones that direct pruning over day-0-to-1 of venous connections from these activated large 
capillaries, followed by EC proliferation and an increase in the capillary’s diameter and 
length and recruitment of mural cells over day-1-to-7. The concept of pruning of capillary 
side-branches that would otherwise divert flow to the contiguous venous trees draining the 
adjacent non-ischemic regions is supported by findings of Le Noble et al (and in other 
studies referenced therein) [80]. Arterial obstruction caused unfavorable angles of shear 
stress at the side-branches of certain capillaries within the chick yolk-sac plexus. This was 
accompanied within hours by migration of ECs to close off the side-branches, followed by 
growth of the capillaries into large-diameter collateral-like anastomoses within 24 hours. 
Reorganization of ECs and modest proliferation but not apoptosis were seen; we also 
confirmed the latter two for neo-collateral formation.
Our model does not include a requirement for sprouting capillary angiogenesis, given the 
rapid time-course for onset of neo-collateral formation and retrograde perfusion (Figures 2 
and 3). Also, the pattern of proliferation of collateral ECs (Online Figure 18) during the 7 
days of pulse-labeling after LADX, ie, widely separated ECs rather than large numbers of 
adjacent ECs, does not fit the pattern expected for newly formed capillaries. Proliferation of 
ECs and additional muralization by SMCs after day-7 would further increase diameter and 
length of the nascent collaterals, resulting in the characteristic tortuous morphology seen by 
day-14 and thereafter (Figure 2). We did not detect involvement of apoptosis (albeit staining 
was confined to day-7), or evidence of proliferation of αSMC+ cells by EdU labeling. We 
thus propose that muralization arises from differentiation of pericytes or fibroblasts or their 
mesenchymal precursors into SMCs. SMCs could also migrate from the distal-most 
arterioles anastomosed by the nascent collateral. We found little evidence for engraftment of 
CCR2- or CX3CR1-positive cells (Figure 6) or other bone-marrow derived cells (Online 
Figures 13,14), and it was not possible to determine if occasional positive cells close-to/
within the collateral wall were undergoing diapedesis (Figure 6B,C). In contrast, marker-
expressing cells in the vicinity of the neo-collaterals were much more abundant (Figure 6, 
Online Figures 13,14), supporting a paracrine role for these cells. Interestingly, injection of 
pericytes into the border zone following acute MI in mice supported myocardial repair [81].
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The above model differs significantly from how native collaterals form during the perinatal 
period (collaterogenesis), a process that determines the extent of the native collateral 
circulation in the adult [17,18]. Collaterogenesis does not appear to require ischemia or 
increased shear stress. Instead, it consists of an angiogenic-like arteriolar sprouting 
mechanism that begins in the last third of gestation and that is followed by SMC 
muralization requiring several weeks to reach completion [18]. Collaterogenesis has thus far 
been shown to involve the Dce1 locus [15] and NFκB→VEGF-
A→Flk1→synectin→notch→Dll4→ADAM-10,-17 signaling, as well as Cnx-37,-40 and 
CLIC4 [18 and references therein,82,83]. The present study shows that neo-collateral 
formation in the ischemic heart varies with genetic background, but with a strain-specific 
pattern different from that seen for the differences in collaterogenesis that occur in the same 
strains. This indicates that different mechanisms direct collaterogenesis and neo-collateral 
formation. The basis for the difference in collateral formation among these strains is not 
known. Of note, the pattern for thioglycolate-induced accumulation of macrophages into the 
peritoneum was B6>BALB/c>A/J and for MCP1 levels in peritoneal fluid was 
B6<BALB/c=A/J [84], consistent with the role of MCP1→CCR2 signaling in neo-collateral 
formation.
Neo-collateral formation also differs from collateral remodeling. Remodeling requires, 
among other BMCs, T cells [1,6,54,55] that were not required for neo-collateral formation. 
Remodeling also requires increased shear stress but not ischemia in the vicinity of the 
collaterals in hindlimb models [1.22]. In contrast, ischemia is present in the watershed/
borderzone region of the heart after acute MI [2,3,7], where native collaterals reside and 
neo-collaterals form. Yet both mechanisms require recruitment of paracrine-acting myeloid 
cells and MCP1→CCR2 and fractalkine→CX3CR1 signaling [1,6,54,55]. Interestingly, 
native collateral extent in brain and hindlimb is not altered in MCP1−/− mice (Online Figure 
20). This is consistent with our evidence discussed above, as well as the requirement for 
MCP1 signaling for collateral remodeling in hindlimb as shown by others [1,6,22], that the 
signaling pathway that stimulates neo-collateral formation differs from that directing 
collaterogenesis and collateral remodeling in tissues studied thus far.
In conclusion, this is the first study to examine whether new collaterals can form in the adult 
heart. We were aided by the unexpected finding that mice lack a native coronary collateral 
circulation, as this permitted us to eliminate remodeling of pre-existing collaterals after 
acute MI as a confounder. Although this absence is unique among mammals studied, there is 
evidence that a significant percentage of humans have poor coronary collaterals [4]. Neo-
collateral formation was rapid and accompanied by smaller infarcts and better recovery of 
heart function. Bone-marrow-derived myeloid cells and MCP1→CCR2 and 
fractalkine→CX3CR1 signaling were required, with little evidence for engraftment. We also 
found that neo-collateral formation varied with genetic background, and with a pattern 
suggesting the underlying pathway differs from that responsible for formation of the native 
collateral circulation during development. By reducing ischemia and speeding delivery of 
immune and progenitor cells, neo-collaterals may promote rescue of ischemic 
cardiomyocytes and regeneration of new ones thus lessening infarct progression, promote 
efficient scar formation, protect against unfavorable remodeling, and thus improve recovery 
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after acute MI. This study presents a model and set of methods to investigate these 
questions. Previous trials of therapies shown in animal studies to augment angiogenesis and 
collateral remodeling have met with limited success [1–4,54,55,85]. While many factors 
have been suggested to underlie this discordance, an understanding of the biology of neo-
collateral formation may lead to identification of novel genes/pathways to test in patients, 
including those where surgical revascularization is not an option, to enhance recovery.
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Non-standard Abbreviations and Acronyms
αSMA α-smooth muscle actin
B6 C57BL/6 mouse strain
BLKS C57BLKS mouse strain
BMC bone marrow-derived cell
CAD atherosclerotic coronary artery disease
CCR2 chemokine CC motif receptor-2
CX3, CR1 chemokine CXC motif receptor-1
CCL chemokine CC motif ligand
EdU 5-ethynyl-2´-deoxyuridine
EC endothelial cell
EPC endothelial progenitor cell
LADX left anterior descending coronary artery ligation
dp/dt+/− derivative of left ventricular pressure rise/fall
LVED/SP left ventricular end-diastolic/systolic pressure
MI myocardial infarction
MCP1 monocyte chemoattractant protein-1
MSC mesenchymal stem/stromal cell
SDF1 stromal-derived factor-1
SMC smooth muscle cell
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• 1st demonstration that de-novo neo-collateral formation (NCF) occurs after acute 
MI
• Neo-collaterals form rapidly in 1–2 days; formation varies with genetic 
background
• Infarct volume and recovery of pump function correlate with amount of NCF
• Bone-marrow myeloid cells, MCP→CCR2 and fractalkine→CX3CR1 signaling 
are required
• NCF may speed immune/progenitor cell delivery to aid regeneration & scar 
formation
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Figure 1. Mice lack native coronary collaterals
A–E, Three months-old C57BL/6 (B6) mice received acute ligation of the distal left anterior 
descending artery (LADX), followed by coronary infusion at 100 mmHg of papavarine and 
nitroprusside in PBS for maximal dilation, then 4% paraformaldehyde (PFA); MicrofilR was 
then infused at a viscosity and pressure that fills all pre-capillary vessels. Panel A is before 
and B–E are after optical clearing with methyl salicylate. Absence of MicrofilR in the LAD 
artery tree below the ligation (infarct zone, IFZ), including in C where capillaries and some 
venules were also filled by using a higher pressure, indicates absence of native collaterals is 
not from failure to fill the smallest-diameter vessels. D, RCA, right coronary artery. E, 
Higher magnification of panel D from endocardial side. Data are representative of ≥ 10 B6 
adults. The same lack of collaterals was obtained in: adult BALB/c, A/J, C57BLKS (BLKS), 
SJL, CBA, DBA/2, C3H-He and CD1 strains (≥ 5 of each strain); after transection of the 
LAD below the ligation to create a minimum-resistance pathway; after endothelial staining 
using ephrin-B2LacZ/+ B6 mice or infusion of the coronary circulation with isolectin-B4-
Alex568; and during perfusion with Evans blue-PBS (see Online Figures 1–5) (≥ 3 mice per 
last 4 procedures).
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Figure 2. New collaterals rapidly form in mice after ligation of the distal LAD tree (LADX)
The “neo-collaterals “ cross-connect the LAD tree to the right coronary (CA) and septal 
artery trees. Same methods as in Figure 1 were used. A, Neo-collaterals (arrows) provide 
partial back-filling of LAD tree 2 days after LADX. IFZ, infarct zone. B, Arrows are several 
superficial neo-collaterals to right coronary artery tree; neo-collaterals on day-7 provide 
complete back-filling of LAD tree (See also Online Figures 10,12). C, Micro-CT imaging 
with Scanco40 at maximal resolution shows complete back-filling but is unable to resolve 
neo-collaterals. D, Epicardial neo-collaterals (arrows) after removal of the underlying 
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myocardium and opposite LV wall to aid imaging. E, Time-course for neo-collateral 
formation after LADX in C57BL/6 mice; number (n) of mice given at base of bars in this 
and subsequent figures. Maximal number and average diameter of the neo-collaterals are 
achieved by 7 days.
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Figure 3. Formation of neo-collaterals after LAD ligation varies with genetic background (A,B) 
and correlates with relative conductance−1 of the newly-formed collateral network (C) and 
infarct volume (D)
A,B, Number and average diameter determined, as in Figure 2, one week after LADX. C, 
images on left, Time required from start of pump (0 sec) to achieve retrograde filling back to 
point of ligation of LAD (18 sec, B6 mouse, backfilled branches of LAD evident; See 
Online figure 10 for video); main bar graph, MicrofilR was at same viscosity and pressure 
for all strains; methods same as in Figure 1 but without optical clearing; insert bar graph, 
Fill-time on indicated days (n=10,9,4,8 mixed male and female B6 mice); no filling was 
seen at ≥ 5 min on day-0, consistent with no native collaterals (Figures 1,2), thus time 
labeled as “infinity” (∞). D, Infarct volume. E, Infarct volume correlated with retrograde 
fill-time; MCP-1−/− and CCR2−/− data points are associated with data in Figure 6. Key and 
statistics in A are for all panels; B6, C57BL/6; BLKS, C57BLKS. Data in panels A-D are 
from different mice.
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Figure 4. Less neo-collateral formation, less collateral network conductance and larger infarct 
volume in A/J strain versus B6 strain (see Figure 3) associated with greater deficit in ventricular 
function (A). Histology of neo-collaterals (B–E)
A, Left ventricular pressure over 1 cardiac cycle. Bottom panel, values determined 7 days 
after LAD ligation. B,C, Neo-collaterals (red arrows, 18 and 45 µm lumen diameter) with 
MicrofilR in lumen (B) or after floating out (C, star). Myocardial cells (large blue-red cells) 
evident near neo-collaterals and venules. D, Endocardial view of piece of ventricular wall 
bordering the infarct zone with neo-collateral (9 µm) indicated by red arrow. E, a-smooth 
muscle actin+ cells surrounding lectin+ endothelial cells of a neo-collateral 7 days after 
ligation; MicrofilR can be seen faintly in lumen in this and certain other figures in paper. See 
Online Figure 12 for methods. Data are representative of ≥ 3 mice at each time-point and 
each staining.
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Figure 5. Neo-collateral formation 1 week after LAD ligation is dependent on MCP-1 →CCR2 
signaling
A–D, number, diameter, retrograde fill time and infarct volume determined as in Figure 3. 
CCR2−/− mice have impaired neo-collateral formation. “conductance” and increased infarct 
volume. MCP-1−/− show smaller difference from C57BL/6 (B6), possibly owing to other 
MCP isoforms acting at CCR2. E, Neo-collaterals of both MCP-1−/− and CCR2−/− mice 
have αSMA+ mural cells; magnification bars, 5 um; data are representative of ≥ 3 mice of 
each. Statistics are versus B6 (background of knockout mice).
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Figure 6. CCR2RFP/+ and CX3CR1
GFP/+ B6 reporter mice show both cell types present 
throughout border zone and in vicinity of developing neo-collaterals 5 days after LAD ligation
A–E, Whole mount images. αSMA+ mural cells surround neo-collaterals and myofibroblast-
like cells present in interstitium. Almost no CCR2+ or CX3CR1+ cells seen in remote zone 
and none within the vicinity of arterioles or venules (Online Figure 17). F,G, 7µm sections 
from border zone; many fewer CCR2+ or CX1CR3+ cells seen 1 day after LADX (n=5 mice, 
data not shown). H, Neo-collaterals (COL) in border zone. Upper panels: arrows identify 
both cells types; Flk1+ cells identify endothelial cells of collateral and nearby vessels, and 
possible monocyte-like EPCs (*). Quantification: cell number counted within area extending 
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1-collateral diameter outward and averaged for 5 sections separated by 50µm from midpoint 
of 1 neo-collateral for each mouse; 5 mice 5 days after LADX were studied.
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A–D, Bone-marrow–derived cells home to myocardium. Wildtype B6 mouse 7 weeks 
after bone-marrow (BM) transplant with B6-GFP-expressing BM cells, and 7 days after 
LAD ligation. Confocal images (A, coronal section of heart at low magnification) show high 
number of cells in border zone (A,D), intermediate number surrounding core/scar region 
(A,C), low number in remote zone (A,B) and very low number in core/scar (A,C). BM cells 
also evident in epicardial and endocardial surface layers. E, Transplant of wildtype BM cells 
rescues deficient neo-collateral formation, and transplant of CCR2−/− BM cells inhibits 
normal neo-collateral formation in wildtype (B6) and CCR2−/− mice 1 week after LAD 
ligation. Methods are same as in Figure 2. Controls (bars 3 and 4 in each graph) show no 
effect of the transplant procedure. *, **, *** p<0.05, 0.01, 0.001. Figure 7F. Model of neo-
collateral formation. Blood flow in the capillary plexus in watershed areas between trees 
normally returns via contiguous venous trees (curved black arrows), consistent with Evans 
blue perfusion data shown in Online Figures 3–5. Arterial obstruction causes ischemia and 
increased fluid shear stress, the latter especially in the largest-diameter capillary(s). MCP1, 
fractalkine and presumably other factors activate CCR2, CX3CR1 and other proteins, 
leading to recruitment of immune cells and vascular and/or hematopoietic progenitors from 
bone marrow and possibly additional sites. The resulting milieu of “remodeling” and growth 
factors directs pruning of venous connections from the largest capillaries over day 0–1, 
followed by increase in diameter, length and mural cell recruitment over day 1–7.
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